February 13, 2020
Rose
Drugmakers argue that they've pumped millions into research and so they can charge a lot more for drugs that used to be available cheaply. But experts find flaws in their logic. In other pharmaceutical news: the price of insulin and CVS' fourth-quarter profits.
from Kaiser Health News https://ift.tt/3bBFvDZ
February 13, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life Care- Nursing Homes Are Suing the Friends and Family of Residents to Collect Debts
- Citing a Mental Health Crisis Among Young People, California Lawmakers Target Social Media
- Journalists Detail the Scope of the Abortion Ruling, Monkeypox, and Public Health Powers
- What the Polio Case in New York Tells Us About the End of Polio
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment